A Multicentre Observational Study to Evaluate the Real-Life Effectiveness of Benepali Following Transition From Enbrel in Patients With Rheumatoid Arthritis (RA) and Axial Spondyloarthritis (axSpA) - The BENEFIT Study
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis; Axial spondyloarthritis; Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms BENEFIT
- Sponsors Biogen
- 30 Jun 2020 Results evaluating the effectiveness and safety of the etanercept biosimilar SB4 following transition from reference etanercept, published in the Clinical and Experimental Rheumatology.
- 23 Jul 2019 According to an Biogen media release, data from this study was presented at the Annual European Congress of Rheumatology (EULAR 2019) in Madrid, Spain (June 12-15, 2019).
- 18 Jun 2019 Status changed from recruiting to completed.